Arsil%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520dx

# Arsil-dx (Commonly refers to a combination of Dextromethorphan + Chlorpheniramine/Antihistamines) *Note: "Arsil-dx" is often a regional brand name for cough and cold preparations. Composition varies significantly by market. This information assumes the standard combination of Dextromethorphan HBr (antitussive) and Chlorpheniramine Maleate (antihistamine).* ## Overview Arsil-dx is a combination product used for the symptomatic relief of upper respiratory symptoms associated with the common cold, allergic rhinitis, or bronchitis. Dextromethorphan suppresses the cough reflex; Chlorpheniramine provides relief from rhinorrhea, sneezing, and pruritus. ## Primary Indications * Symptomatic relief of cough due to minor throat/bronchial irritation. * Relief of sneezing, runny nose, and itchy/watery eyes. ## Adult Dosing * **Dextromethorphan/Chlorpheniramine:** Typically 10–20 mg / 2–4 mg orally every 6–8 hours as needed. * **Maximum Dose:** Do not exceed 120 mg of Dextromethorphan or 24 mg of Chlorpheniramine in 24 hours. ## Pediatric Dosing * **Age 6–12 years:** 5–10 mg / 1–2 mg orally every 6–8 hours as needed. * **Under 6 years:** Not recommended without direct physician supervision due to risk of serious adverse events. * **Maximum Dose:** Follow specific product labeling or pediatric weight-based guidelines provided by a specialist. ## Dose Adjustments * **Renal/Hepatic Impairment:** Reduce frequency or total daily dose. No standardized dosing available; use with caution. * **Geriatric:** Increased risk of anticholinergic side effects (urinary retention, confusion, sedation); use the lowest effective dose or avoid if possible. ## Contraindications * Hypersensitivity to any component. * Concurrent use of MAOI therapy (within 14 days). * Narrow-angle glaucoma, symptomatic prostatic hypertrophy, or bladder neck obstruction. * Asthmatic attacks or severe respiratory depression. ## Adverse Effects * **Common:** Drowsiness, dizziness, dry mouth, blurred vision, thick bronchial secretions. * **Serious:** Urinary retention, paradoxical excitation (in children), tachycardia, confusion. ## Key Drug Interactions * **MAOIs:** Risk of serotonin syndrome or hypertensive crisis. * **CNS Depressants:** Alcohol, sedatives, or opioids may cause severe additive CNS depression. * **CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine):** May increase levels/toxicity of Dextromethorphan. ## Monitoring * Monitor for symptom progression (cough persisting >7 days). * Monitor for signs of anticholinergic toxicity (tachycardia, dry mucous membranes, confusion). * Assess for CNS depression (avoid driving or operating machinery). ## Clinical Pearls * **Combination Risk:** Always verify the "DX" component formulation, as some versions include additional ingredients like Phenylephrine or Guaifenesin. * **Underlying Cause:** Product masks symptoms; do not use for chronic cough (e.g., asthma, emphysema, or smoking-related) without medical evaluation. * **Hydration:** Instruct patients to increase fluid intake to help thin bronchial secretions. *** **Educational Disclaimer:** This information is for educational purposes only. Drug formulations and local prescribing guidelines vary significantly. Always verify the specific product label, local protocols, and current package inserts before prescribing or administering medication. Consult a clinical pharmacist or the manufacturer's official documentation for definitive data.